LOGIN  |  REGISTER
Recursion

Evolent Health To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024

October 11, 2024 | Last Trade: US$9.23 0.06 -0.65
  • Company to Participate in Upcoming Conferences

WASHINGTON, Oct. 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its third quarter 2024 financial results on Thursday, November 7, 2024, after market close, with a conference call to follow at 5 p.m. ET.

Shareholders and interested participants may listen to a live broadcast of the conference found on Evolent's investor relations website, https://ir.evolent.com.

Analysts interested in asking questions during the live call should dial 855.940.9467, or 412.317.6034 for international callers, and reference the "Evolent call" 15 minutes prior to the call.

An audio playback of the conference call will be available on Evolent's investor relations website for 90 days after the call.

Upcoming Investor Events

Additionally, The Company announced that its executive management team will participate in upcoming investor conferences.

A live audio-only webcast and replay for these events will be available on the "Events and Presentations" section of Evolent's investor relations website. Specific presentation times will be posted on the website as they become available.   

  • Stephens 2024 Annual Investment Conference at the Grand Hyatt Nashville Hotel, Nashville, Tennessee, on November 20, 2024.

  • BTIG 2024 Digital Health Forum to be held virtually on November 25, 2024. A live webcast of management's presentation will take place at 3:00 p.m. ET.

  • Citi 2024 Global Healthcare Conference at the InterContinental Miami Hotel, Miami, Florida, on December 3, 2024. A live webcast of management's presentation will take place at 3:15 p.m. ET.

  • Piper Sandler 36th Annual Healthcare Conference in New York, New York, on December 3, 2024.

  • 43rd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, California, scheduled for January 13-16.

About Evolent 

Evolent specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting https://ir.evolent.com.

Contacts:

Seth R. Frank
Vice President, Investor Relations
Evolent
This email address is being protected from spambots. You need JavaScript enabled to view it.
571-895-3919 (W)

Astria Therapeutics

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page